Q1 2025 · 13F-HR
Venrock Adviser, LLCholdings as filed
Filed 2025-05-15 · accession 0001415889-25-013093
$1.18B
Reported value
37
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $317.3M | 27.0% | 8,493,321 | Common | SOLE |
| 59267L107 | — | METSERA INC | $102.1M | 8.69% | 3,750,662 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $93.5M | 7.96% | 12,762,462 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $79.2M | 6.74% | 4,026,331 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $77.4M | 6.58% | 6,703,985 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $52.3M | 4.45% | 3,882,709 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $48.9M | 4.16% | 3,112,720 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $43.3M | 3.69% | 2,685,448 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $42.6M | 3.62% | 4,148,428 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $37.5M | 3.19% | 989,985 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $34.0M | 2.90% | 5,684,411 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $31.6M | 2.69% | 1,744,373 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $22.7M | 1.93% | 2,173,913 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $22.6M | 1.93% | 1,051,518 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $22.6M | 1.92% | 5,046,414 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $22.2M | 1.89% | 16,216,216 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $17.8M | 1.51% | 3,182,527 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $14.0M | 1.20% | 2,295,319 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $13.1M | 1.12% | 2,457,348 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $10.4M | 0.89% | 1,379,965 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $9.2M | 0.78% | 2,481,400 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $9.0M | 0.77% | 3,257,639 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $8.4M | 0.72% | 1,345,780 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.7M | 0.66% | 750,000 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $7.4M | 0.63% | 632,931 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $6.5M | 0.55% | 5,023,166 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $4.8M | 0.41% | 1,609,569 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $3.9M | 0.33% | 615,506 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $2.7M | 0.23% | 5,567,709 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $2.2M | 0.19% | 677,600 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $2.1M | 0.18% | 987,259 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $1.4M | 0.12% | 208,333 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $1.2M | 0.10% | 3,574,325 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $1.2M | 0.10% | 2,498,069 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $886,822 | 0.08% | 1,555,556 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $630,000 | 0.05% | 3,000,000 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $575,953 | 0.05% | 33,177 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.